医疗工业
Search documents
美股异动丨雷克兰医疗工业盘前大跌近23% Q3业绩亏损,撤回2026财年展望
Ge Long Hui· 2025-12-10 09:40
Core Viewpoint - Lake Medical Industries (LAKE.US) experienced a significant pre-market decline of 22.7% to $11.6 following the announcement of a substantial earnings miss for Q3 of fiscal year 2025, with a diluted net loss per share of $1.64 compared to analyst expectations of a profit of $0.23 and a prior year earnings of $0.01 [1] Financial Performance - The company reported a diluted net loss per share of $1.64 for Q3 of fiscal year 2025, which is a significant deviation from analyst expectations of a profit of $0.23 [1] - The previous year's earnings were reported at $0.01 per share, indicating a substantial decline in performance year-over-year [1] Future Outlook - Due to various macroeconomic factors, the company has decided to withdraw its previously issued guidance for fiscal year 2026 and will not provide future financial guidance [1]
塞力医疗:11月11日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-11-11 08:57
Group 1 - The core point of the article is that Sely Medical (SH 603716) held a temporary board meeting on November 11, 2025, to discuss the proposal for providing guarantee limits for its subsidiary [1] - For the fiscal year 2024, Sely Medical's revenue composition is 97.09% from commercial activities and 2.91% from industrial activities [1] - As of the report date, Sely Medical has a market capitalization of 4.9 billion yuan [1] Group 2 - Prior to the arrest of Peking University Pharmaceutical's chairman Xu Xiren, police had investigated the group's factory premises, indicating potential issues within the company [1] - Internal sources suggest that the group's assets have been disposed of by Xu, with significant amounts of funds unaccounted for [1]
阳普医疗:8月13日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-14 10:57
Group 1 - The core viewpoint of the article highlights that Yangpu Medical (SZ 300030) held its 14th meeting of the 6th board of directors on August 13, 2025, to review the "2025 Semi-Annual Report" and other documents [1] - For the year 2024, Yangpu Medical's revenue composition shows that industrial revenue accounts for 99.18%, while financing leasing contributes 0.82% [1] - As of the report, Yangpu Medical has a market capitalization of 2.6 billion yuan [1]